Viropharma, Inc. (VPHM) Tops Q4 EPS by 7c; Guides FY Sales In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Wells Fargo Adds ViroPharma (VPHM) to Its Priority List
March 1, 2013 10:17 AM ESTWells Fargo today added ViroPharma Inc. (Nasdaq: VPHM) to its priority stock list, calling the stock its highest conviction mid-cap biotech idea.
Analysts said they have continued conviction that there is a significant discount between the stock's current valuation and the company's strong... More

